Literature DB >> 9927305

Initiation of increased pancreatic islet growth in young normoglycemic mice (Umeå +/?).

A Edvell1, P Lindström.   

Abstract

Pancreatic islets from obese hyperglycemic mice are large and contain a high proportion of normally functioning beta-cells. We have previously shown that young obese mice have an elevated beta-cell proliferation rate at 3 weeks of age. We now wanted to investigate possible factors involved in the initiation of islet growth, including blood glucose, C peptide, glucagon-like peptide-1, vasoactive intestinal polypeptide, and L-5-hydroxytryptophan. We found that the increased beta-cell proliferation on day 20 precedes the rise in blood glucose by 2 days. The islet cell proliferation, measured as the 5-bromo-2'-deoxyuridine labeling index, in 20-day-old lean mice, was enhanced in a dose-dependent manner when glucagon-like peptide-1 or C peptide was injected s.c. for 2 days. L-5-Hydroxytryptophan inhibited the proliferation. C Peptide also increased the islet cell labeling index during islet culture. We conclude that in addition to the effect of glucose, islet proliferation can be triggered by other factors involved in the physiological regulation of increased insulin release. Stimulation of islet proliferation may be related to the actual release of insulin, and C peptide may function as a mediator of such responses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9927305     DOI: 10.1210/endo.140.2.6514

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  35 in total

Review 1.  The role of gut hormones in glucose homeostasis.

Authors:  Daniel J Drucker
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

2.  Characterization of an N-acylated glucagon-like peptide-1 derivative by electron capture dissociation.

Authors:  Kim F Haselmann; Per F Nielsen; Roman A Zubarev
Journal:  J Am Soc Mass Spectrom       Date:  2005-04       Impact factor: 3.109

Review 3.  Minireview: Meeting the demand for insulin: molecular mechanisms of adaptive postnatal beta-cell mass expansion.

Authors:  Mira M Sachdeva; Doris A Stoffers
Journal:  Mol Endocrinol       Date:  2009-02-05

Review 4.  Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors:  Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

Review 5.  Gastrointestinal hormones regulating appetite.

Authors:  Owais Chaudhri; Caroline Small; Steve Bloom
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

6.  Exendin-4 increases islet amyloid deposition but offsets the resultant beta cell toxicity in human islet amyloid polypeptide transgenic mouse islets.

Authors:  K Aston-Mourney; R L Hull; S Zraika; J Udayasankar; S L Subramanian; S E Kahn
Journal:  Diabetologia       Date:  2011-04-12       Impact factor: 10.122

7.  Evidence for a circulating islet cell growth factor in insulin-resistant states.

Authors:  S N Flier; R N Kulkarni; C R Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

8.  Lentiviral gene therapy vectors encoding VIP suppressed diabetes-related inflammation and augmented pancreatic beta-cell proliferation.

Authors:  Fulya Erendor; Elif Ozgecan Sahin; Ahter D Sanlioglu; Mustafa Kemal Balci; Thomas S Griffith; Salih Sanlioglu
Journal:  Gene Ther       Date:  2020-07-30       Impact factor: 5.250

Review 9.  Advances in β cell replacement and regeneration strategies for treating diabetes.

Authors:  Jacqueline R Benthuysen; Andrea C Carrano; Maike Sander
Journal:  J Clin Invest       Date:  2016-10-03       Impact factor: 14.808

10.  Functional characterization of N-terminally GFP-tagged GLP-1 receptor.

Authors:  Aljosa Bavec; Alenka Licar
Journal:  J Biomed Biotechnol       Date:  2009-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.